Table 5.
Title of Study | Status | Completion Date | Enrollment | Analysis | Study Results | Pre-Clinical References |
---|---|---|---|---|---|---|
Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: A Prospective Study | Active, not recruiting | September 2021 | 4119 participants (healthy heavy smokers) | Pre-selected panel of 24 miRNAs in plasma | Study not completed | [31,114,115] |
Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT | Active, not recruiting | August 30, 2020 | 479 participants undergoing LDCT (smokers) | Hummingbird Diagnostic´s microRNA test for lung cancer diagnosis in total blood | No results available | Not provided |
MicroRNA Genetic Signature in NSCLC Egyptian Patients | † Completed | August 2016 | 40 participants (20 NSCLC, 10 nonsmokers, 10 smokers) | miRNA signature pattern in NSCLC Egyptian patients (by microarray) | † No results available | Not provided |
Quantification of microRNAs in Diagnosis of Pulmonary Nodules | Completed | May 2019 | 103 participants (patients with nodules >5 mm and <30 mm in the lung parenchyma) | Pre-selected panel of 34 miRNAs | No results available | Not provided |
Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer: Multicenter Controlled Study (RadimiR-01) | † Unknown | Last update posted: March 2017 | Estimated 240 participants (NSCLC) | Unspecified miRNAs in plasma | † No results available | Not provided |
Association between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell Carcinoma | † Unknown | Last update posted: Nov 2010 | Estimated 250 participants (NSCLC) | Unspecified miRNAs in unspecifies biological samples, probably serum | † No results available | Not provided |
LDCT: low-dose computed tomography; NSCLC: non-small-cell lung cancer; † Study has passed its completion date, and status has not been verified in more than two years.